Device and method for depletion of the leukocyte content of blood and blood components

• US 4,925,572 A
• Filed: 10/19/1988
• Issued: 05/15/1990
• Est. Priority Date: 10/20/1987
• Status: Expired due to Term

• Current Assignee: Pall Corporation (Danaher Corporation)
• Original Assignee: Pall Corporation (Danaher Corporation)
• Inventors: Pall, David B.
• Primary Examiner(s): Jones, W. Gary
• Application Number:
  US07/259,773
• Time in Patent Office: 573 Days
• Field of Search: 604/406, 210/645, 210/649, 210/650, 210/651, 210/321, 210/84, 210/767, 210/321.85, 210/435, 210/436, 210/446, 210/488, 210/489, 210/490, 210/491, 210/492, 210/505, 210/508 , 210/806, 210/496
• US Class Current: 210/767
• CPC Class Codes: A61M 1/3633 Blood component filters, e.g. leukocyte filters
• CPC Class Codes: A61M 2202/005 residue retained by the filter due to size
• CPC Class Codes: A61M 2202/0057 retained by adsorption
• CPC Class Codes: A61M 2202/0413 Blood
• CPC Class Codes: A61M 2202/0439 White blood cells; Leucocytes lymphocytes A61M2202/0407
• CPC Class Codes: A61M 2230/005 Parameter used as control input for the apparatus
• CPC Class Codes: B01D 39/04 Organic material, e.g. cellulose, cotton
• CPC Class Codes: B01D 39/14 Other self-supporting filtering material ; Other filtering material non-woven fabrics in general D04H3/00
• CPC Class Codes: B01D 39/1623 of synthetic origin

Abstract

Devices for the depletion of leukocytes in blood products, preferably comprising an upstream porous element including means for removal of gels, at least one intermediate porous element including means for removal of microaggregates, and a downstream element including means for removal of leukocytes by both adsorption and filtration, preferably with at least one of the elements having been modified to a CWST in excess of 53 dynes/cm.

Claims

1. A device for the depletion of the leukocyte content of a blood product comprising at least first, second, and third preformed porous elements with the second element interposed between the first and third elements, each successive element having a smaller pore diameter than that preceding it, the first element including means for removing gels, the second element including means for removing microaggregates, and the third element including means for removing leukocytes in which at least the third element has a CWST of from greater than 53 to less than 90 dynes/cm.

2. The device of claim 1 in which the third element has a pore diameter in the range of from about 4 to about 8 micrometers.

3. The device of claim 2 in which the third element has a pore diameter in the range of from about 4 to about 5.5 micrometers, the device being well suited for processing a blood product of age 2 to about 5 to 10 days.

4. The device of claim 2 in which the third element has a pore diameter in the range of from about 6 to about 8 micrometers, the device being well suited for processing a blood product of age in excess of about 10 days.

5. The device of claim 1 in which the first element in the series comprises a needled fibrous structure.

6. The device of claim 5 in which the first element has been hot compressed to controlled thickness.

7. The device of claim 6 in which the average pore diameter of the first element is such as to require, when prewetted by isopropyl alcohol, a differential pressure of 4 to 7 cm of water column to induce air flow through it at the rate of 0.5 cm/second through the first element.

8. The device of claim 1 in which there are at least two interposed elements comprised of porous media which in at least three steps span in approximate geometric progression the pore diameter range of from about 25 to about 10 micrometers.

9. The device of claim 1 in which there are at least two interposed elements comprised of porous media having progressively stepwise decreasing pore diameters spanning the range of from about 25 to about 10 micrometers.

10. The device of claim 1 in which the pore diameter of a single interposed element varies progressively stepwise from about 25 micrometers down to a pore diameter of about 10 micrometers.

11. The device of claim 1 in which at least one of the elements has been modified to a CWST in excess of about 59 dynes/cm.

12. The device of claim 11 in which at least one of the elements has been modified to a CWST in excess of 63 dynes/cm.

13. The device of claim 1 in which at least one of elements has been modified to a CWST in the range of from greater than 53 to about 75 dynes/cm.

14. The device of claim 13 in which the fibers of at least one of the elements has been surface grafted to a CWST in the range of from greater than 53 to about 70 dynes/cm.

15. The device of claim 1 in which the fibers of at least one of the elements has been surface grafted by exposure to an energy source while in contact with a monomer containing at least one hydroxyl moiety and one moiety capable of activation by an energy source, together with a monomer containing at least one hydrophobic moiety and one moiety capable of activation by an energy source.

16. The device of claim 1 in which the effective cross-sectional area of each of the elements is in excess of 54 square centimeters.

17. The device of claim 16 in which the total voids volume in all the elements is less than 28 milliliters.

18. The device of claim 16 in which the total internal voids volume of the device is less than 37 milliliters.

19. The device of claim 1 wherein the means for removing leukocytes in the third element includes filtration means.

20. A method for the depletion of the leukocyte content of a blood product comprising passing the blood product through the device of claim 1.

21. The device of claim 1 wherein the third element has a CWST of from 55 to less than 90 dynes/cm.

22. A device for the depletion of the leukocyte content of a blood product comprising at least first, second, and third porous elements with the second element interposed between the first and third elements, each successive element having a smaller pore diameter than that preceding it, the first element including means for removing gels, the second element including means for removing microaggregates, and the third element including means for removing leukocytes, and at least the third element has been modified to a CWST of from greater than 53 to less than 90 dynes/cm.

23. The device of claim 22 wherein all of the elements have prior to assembly been compressed to controlled thickness.

24. The device of claim 22, said device consistently providing prior to clogging a capacity of at least two units of blood product of any age up to and including its permissible limit for human use.

25. The device of claim 24 in which at least one of the component elements has prior to assembly been compressed to controlled thickness.

26. The device of claim 24 in which the total voids volume of all the elements is less than 28 milliliters.

27. The device of claim 26 in which the total internal voids volume of the device is less than 37 milliliters.

28. The device of claim 27 in which the total volume of the device is less than 60 milliliters.

29. The device of claim 24 in which the porous elements are fibrous and total surface area of all the fibers is less than 4 square meters.

30. The device of claim 29 in which the pore diameter of the third element is in the range of 4 to 8 micrometers.

31. The device of claim 24 in which the total surface area of all the fibers is less than 3.5 square meters.

32. The device of claim 31 in which the pore diameter of the third element is in the range of 4 to 8 micrometers.

33. The device of claim 22 in which at least one of the component elements prior to assembly has been compressed to controlled thickness.

34. The device of claim 22 wherein the first element includes two or more means for removing gels.

35. A method for the depletion of the leukocyte content of blood product comprising passing the blood product through the device of claim 22.

36. The device of claim 22 wherein the third element has a CWST of from 55 to less than 90 dynes/cm.

40. The device of claim 34 in which the CWST is from about 62 to about 68 dynes/cm.

37. A device for the depletion of the leukocyte content of a blood product comprising at least one integral element preformed of synthetic fibers, the surfaces of said fibers having been grafted to give the element a CWST of from greater than 53 to less than 90 dynes/cm.

38. The device of claim 37 in which the fibers of the element have been surface grafted to increase the CWST of the element by 2 or more dynes/cm.

39. The device of claim 37 in which the CWST is from about 59 to about 73 dynes/cm.

41. The device of claim 37 in which the fibers of at least one element have been surface grafted by exposure to an energy source while in contact with a monomer containing at least one hydroxyl moiety and one moiety capable of activation by an energy source, together with a monomer containing one hydrophobic moiety and one moiety capable of activation by an energy source.

42. The device of claim 37 wherein the fibers of the element has a CWST of from 55 to less than 90 dynes/cm.

43. A device for the depletion of leukocytes from a blood product comprising at least one preformed fibrous filter element in which the fibers of the element have been radiation-grafted and thereafter hot compressed to form a coherent filter element with a CWST of from greater than 53 to less than 90 dynes/cm.

44. The device of claim 43 in which the element has been modified to a CWST in the range of greater than 53 to 75 dynes/cm.

45. The device of claim 43 in which the fibers have been surface grafted by exposure to an energy source while in contact with a monomer containing at least one hydroxyl moiety and one moiety capable of activation by an energy source, together with a monomer containing at least one hydrophobic moiety and one moiety capable of activation by an energy source.

46. A method for the depletion of the leukocyte content of blood product comprising passing the blood product through the device of claim 43.

47. The device of claim 43 wherein the element has a CWST of from 55 to less than 90 dynes/cm.

48. A device for the depletion of the leukocyte content of a blood product comprising at least one preformed integral multilayer element of synthetic fibers including a layer having a CWST of from greater than 53 to less than 90 dynes/cm for removing leukocytes.

49. The device of claim 48 in which the fibers have been surface grafted by exposure to an energy source while in contact with a monomer containing at least one hydroxyl moiety and one moiety capable of activation by an energy source, together with a monomer containing at least one hydrophobic moiety and one moiety capable of activation by an energy source.

50. A method for the depletion of the leukocyte content of blood product comprising passing the blood product through the device of claim 48.

51. The device of claim 48 wherein the layer has a CWST of from 55 to less than 90 dynes/cm.

52. A device for filtering a blood product comprising at least three porous elements, the first element composed of at least in part a needled fibrous web, the second element having a smaller pore size than the first, and the third having a CWST of from greater than 53 to less than 90 dynes/cm.

53. The device of claim 52 in which the second element comprises at least one planar parallel non-woven component.

54. The device of claim 53 in which the second element is disposed between the first and the third elements and in which at least one of the second and third elements has been modified to a CWST within about 2 to 20 dynes/cm of the surface tension of the liquid phase.

55. The device of claim 54, said device consistently providing prior to clogging a capacity of at least two units of a blood product of any age up to and including its permissible limit for human use.

56. The device of claim 55 in which the total voids volume of all the elements is less than 28 milliliters.

57. The device of claim 56 in which the total internal voids volume of the device is less than 37 milliliters.

58. The device of claim 54 in which at least one of the second and third elements has been grafted to a CWST in the range from greater than 53 to about 75 dynes/cm.

59. The device of claim 52 in which at least one of the component elements has prior to assembly been compressed to controlled thickness.

60. The device of claim 59 in which all of the component elements have prior to assembly been compressed to controlled thickness.

61. The device of claim 52 in which the average pore diameter of the first element is such as to require, when prewetted by isopropyl alcohol, a differential pressure of 4 to 7 cm of water column to induce flow of air through it at a rate of 0.5 cms/second through the first element.

62. The device of claim 52 in which the second element has been surface grafted by exposure to an energy source while in contact with a monomer containing at least one hydroxyl moiety and one moiety capable of activation by an energy source, together with a monomer containing at least one hydrophobic moiety and a moiety capable of activation by an energy source.

63. The device of claim 62 which comprises, in part, three or more elements preformed prior to assembly, each with cross-sectional flow area in excess of 54 square centimeters.

64. The device of claim 63 in which the total voids volume of all the elements is less than 28 milliliters.

65. The device of claim 63 in which the total internal voids volume of the device is less than 37 milliliters.

66. A method for the depletion of the leukocyte content of blood product comprising passing the blood product through the device of claim 52.

67. The device of claim 52 wherein the third element has a CWST of from 55 to less than 90 dynes/cm.

68. A device for the depletion of the leukocyte content of a blood product comprising a housing including an inlet and an outlet and defining a fluid flow path between the inlet and the outlet, an upstream porous element, at least one intermediate porous element and a downstream porous element, the upstream element including means for removing gels, the intermediate element including means for removing microaggregates, and the downstream element including means for removing leukocytes and having a CWST of from greater than 53 to less than 90 dynes/cm, the upstream, intermediate, and downstream elements being secured within the housing by an interference fit.

69. A method for the depletion of the leukocyte content of blood product comprising passing the blood product through the device of claim 68.

70. The device of claim 68 wherein the downstream element has a CWST of from 55 to less than 90 dynes/cm.